Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Biomarker-Guided Immunotherapy Discontinuation for Melanoma
Recruiting1 awardPhase 2
Peoria, Illinois
This trial is testing if doctors can safely shorten the use of anti-PD1 therapy for melanoma by using biomarkers seen on PET/CT imaging and tumor biopsy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.